These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 21594291

  • 1. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
    Wang L, Alcon A, Yuan H, Ho J, Li QJ, Martins-Green M.
    Integr Biol (Camb); 2011 Jul; 3(7):742-54. PubMed ID: 21594291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB, Bajo AM, Sánchez-Chapado M, Prieto JC, Carmena MJ.
    Prostate; 2009 May 15; 69(7):774-86. PubMed ID: 19189304
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.
    Ma S, Chan YP, Kwan PS, Lee TK, Yan M, Tang KH, Ling MT, Vielkind JR, Guan XY, Chan KW.
    Cancer Res; 2011 Jan 15; 71(2):583-92. PubMed ID: 21224345
    [Abstract] [Full Text] [Related]

  • 7. p65-Dependent production of interleukin-1β by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts.
    Schulze J, Weber K, Baranowsky A, Streichert T, Lange T, Spiro AS, Albers J, Seitz S, Zustin J, Amling M, Fehse B, Schinke T.
    Cancer Lett; 2012 Apr 01; 317(1):106-13. PubMed ID: 22108531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Valproic acid inhibits prostate cancer cell migration by up-regulating E-cadherin expression.
    Zhang L, Wang G, Wang L, Song C, Wang X, Kang J.
    Pharmazie; 2011 Aug 01; 66(8):614-8. PubMed ID: 21901986
    [Abstract] [Full Text] [Related]

  • 10. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
    Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM.
    Carcinogenesis; 2006 Oct 01; 27(10):1980-90. PubMed ID: 16606632
    [Abstract] [Full Text] [Related]

  • 11. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G.
    Cancer Res; 2006 May 15; 66(10):5012-20. PubMed ID: 16707422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
    Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC.
    Cancer Prev Res (Phila); 2009 Sep 15; 2(9):830-41. PubMed ID: 19737984
    [Abstract] [Full Text] [Related]

  • 14. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW.
    Clin Cancer Res; 2004 Dec 15; 10(24):8743-50. PubMed ID: 15623660
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ, Pantuck AJ, Paik SH, Zisman A, Graeber TG, Eisenberg D, McBride WH, Nguyen D, Tso CL, Belldegrun AS.
    Prostate; 2003 Jun 01; 55(4):299-307. PubMed ID: 12712409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O.
    Cancer Res; 2011 Mar 01; 71(5):1956-67. PubMed ID: 21343391
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.